Search

everythinglearnresearchcommunity

for

Search:↓

A man with vitiligo and alopecia saw quick skin and hair improvement with ruxolitinib, but skin color gains were lost after stopping treatment.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

Tofacitinib therapy can effectively regrow eyebrows and eyelashes in some alopecia areata patients.

A PTH-based treatment improved hair regrowth better than ruxolitinib in a mouse model of hair loss.

Ruxolitinib helped a woman with a genetic mutation regrow her hair and improved her health.

A 15-year-old boy's severe scalp condition improved significantly with adalimumab and baricitinib treatment.

Baricitinib works better than methotrexate for severe alopecia areata.

Baricitinib helps regrow hair in severe alopecia areata but has side effects like infections and headaches.

Ruxolitinib cream effectively targets and treats inflammatory skin diseases.

A man developed skin issues from cancer medication, which improved with specific treatments.

Tyrosine kinase inhibitors effectively treat cancers but often cause skin and other side effects.

Janus kinase inhibitors may effectively treat resistant scalp conditions like folliculitis decalvans and dissecting cellulitis.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.

Ruxolitinib effectively and safely regrows hair in alopecia patients.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Ritlecitinib improves hair regrowth in alopecia areata without increasing adverse risks.

Dabrafenib was effective and well tolerated in treating thyroid cancer with a specific mutation.

Baricitinib shows promise as a new treatment for certain skin conditions like alopecia areata.

Abrocitinib shows promise for treating various skin conditions beyond atopic dermatitis.

Ritlecitinib effectively maintains hair regrowth in alopecia areata patients.

Oral betamethasone works faster than oral tofacitinib for hair regrowth in alopecia areata.

Baricitinib significantly improved hair regrowth and skin condition in a 14-year-old with alopecia areata and atopic dermatitis.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

Baricitinib was effective in regrowing hair in patients with different levels of alopecia areata severity.

Oral and topical tofacitinib can effectively treat severe hair loss with minimal side effects.

Deuruxolitinib is approved to treat severe alopecia areata in adults.

Deucravacitinib did not significantly improve hair regrowth in alopecia areata patients.

Tofacitinib effectively improved severe skin symptoms in a patient with Hypohidrotic Ectodermal Dysplasia.

Topical JAK inhibitors may help children with alopecia areata regrow hair.